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Crystal Structure of the H256A Mutant of Rat Testis
Fructose-6-phosphate,2-kinase/Fructose-2,6-bisphosphatase
FRUCTOSE 6-PHOSPHATE IN THE ACTIVE SITE LEADS TO MECHANISMS FOR BOTH MUTANT AND WILD
TYPE BISPHOSPHATASE ACTIVITIES*
(Received for publication, July 14, 1998, and in revised form, August 26, 1998)

Mi H. Yuen‡, Hiroyuki Mizuguchi§¶, Yong-Hwan Lee‡, Paul F. Cooki, Kosaku Uyeda§¶, and
Charles A. Hasemann‡§**
From the Departments of ‡Internal Medicine and §Biochemistry, University of Texas Southwestern Medical Center,
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iDepartment of Chemistry and Biochemistry, University of Oklahoma, Norman, Oklahoma 73019

Fructose-6-phosphate,2-kinase/fructose-2,6-bisphosphatase (Fru-6-P,2-kinase/Fru-2,6-Pase) is a bifunctional
enzyme, catalyzing the interconversion of b-D-fructose6-phosphate (Fru-6-P) and fructose-2,6-bisphosphate
(Fru-2,6-P2) at distinct active sites. A mutant rat testis
isozyme with an alanine replacement for the catalytic
histidine (H256A) in the Fru-2,6-Pase domain retains
17% of the wild type activity (Mizuguchi, H., Cook, P. F.,
Tai, C-H., Hasemann, C. A., and Uyeda, K. (1998) J. Biol.
Chem. 274, 2166 –2175). We have solved the crystal structure of H256A to a resolution of 2.4 Å by molecular replacement. Clear electron density for Fru-6-P is found at
the Fru-2,6-Pase active site, revealing the important interactions in substrate/product binding. A superposition of the H256A structure with the RT2K-Wo structure
reveals no significant reorganization of the active site
resulting from the binding of Fru-6-P or the H256A mutation. Using this superposition, we have built a view of the
Fru-2,6-P2-bound enzyme and identify the residues responsible for catalysis. This analysis yields distinct catalytic mechanisms for the wild type and mutant proteins.
The wild type mechanism would lead to an inefficient
transfer of a proton to the leaving group Fru-6-P, which
is consistent with a view of this event being rate-limiting, explaining the extremely slow turnover (0.032 s21)
of the Fru-2,6-Pase in all Fru-6-P,2-kinase/Fru-2,6-Pase
isozymes.

The bifunctional enzyme fructose-6-phosphate,2-kinase/fructose-2,6-bisphosphatase (Fru-6-P,2-kinase1/Fru-2,6-Pase) participates in glucose homeostasis by regulating the intracellular
* This work was supported by grants from the Welch Foundation, the
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DK16194 (to K. U.) and GM36799 (to P. F. C.). The costs of publication
of this article were defrayed in part by the payment of page charges.
This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The atomic coordinates and structure factors (code 2bif) have been
deposited in the Protein Data Bank, Brookhaven National Laboratory,
Upton, NY.
** To whom correspondence should be addressed: Dept. of Internal
Medicine, UT Southwestern Medical Center, 5323 Harry Hines Blvd.,
Dallas, TX 75235-8884.
1
The abbreviations used are: Fru-6-P,2-kinase, fructose-6-phosphate,2-kinase; Fru-2,6-Pase, fructose-2,6-bisphosphatase; Fru-2,6-P2,
fructose-2,6-bisphosphate; Fru-6-P, b-D-fructose-6-phosphate; AMPPNP, 59-adenylyl imidodiphosphate; RL2K, rat liver isozyme of fructose-6-phosphate,2-kinase/fructose-2,6-bisphosphatase; RT2K, rat testis isozyme of fructose-6-phosphate,2-kinase/fructose-2,6-bisphosphatase; RT2K-Wo, RT2K with all four tryptophans mutated to phenylala-

concentration of fructose-2,6-bisphosphate (Fru-2,6-P2). Fru2,6-P2 is both a potent physiological activator of 6-phosphofructokinase, and an in vitro inhibitor of fructose-1,6-bisphosphatase (reviewed in Refs. 2– 4). There is significant sequence
homology among the Fru-2,6-Pase domain, the phosphoglycerate mutases, and the acid phosphatases (5, 6). We previously
determined the crystal structure of the rat testis Fru-6-P,2kinase/Fru-2,6-Pase (RT2K-Wo), showing the enzyme to be a
head-to-head homodimer of 55-kDa subunits, with each monomer consisting of independent kinase and phosphatase domains (7). The kinase domains are in close contact, forming an
extended hydrophobic core between them, while the phosphatase domains are essentially independent of one another. The
structure of the isolated rat liver Fru-6-P,2-kinase/Fru-2,6Pase (RL2K) Fru-2,6-Pase domain has also been determined
(8), and as would be predicted by the 85% identity between the
Fru-2,6-Pase domains, the structures are nearly identical.
Comparison of the RT2K-Wo Fru-2,6-Pase domain structure
with those of yeast phosphoglycerate mutase (9) and rat acid
phosphatase (10) confirmed that these enzymes also have very
similar tertiary structures (7). These enzymes share a common
catalytic mechanism involving a covalent phosphohistidine intermediate (11–14) located in a conserved sequence motif
(ZXRHG(E/Q)XXXN, where Z is a hydrophobic residue (15)).
The sequence motif 253LCRHGESELN262 is found in the RT2K
phosphatase domain, where His256 is the catalytic histidine.
This conserved sequence motif, together with Arg305, Glu325,
and His390, forms a larger conserved structural motif defining
the catalytic center of all three enzymes (7).
Mutagenesis and kinetic analyses on the rat liver isozyme
(16 –20) led to a model of Fru-2,6-P2 binding and a potential
phosphatase reaction mechanism. Thus, the catalytic histidine
(His258 in RL2K, His256 in RT2K) was proposed to make a
nucleophilic attack on the 2-phosphate of Fru2,6-P2, while positively charged side chains (Arg257 and Arg307 in RL2K, Arg255
and Arg305 in RT2K) orient the 2-phosphate and stabilize the
transition state. His392 (His390 in RT2K) was proposed to be
coupled to Glu327 (Glu325 in RT2K), making His392 doubly
protonated, and capable of donating a proton to the leaving
group oxygen of Fru-6-P. A water, activated by Glu327, would
then attack the phosphoenzyme intermediate, regenerating the
enzyme and producing a free PO4 ion (8, 14). This interpretation of the mutagenesis and the proposed reaction mechanism
are largely in agreement with the RT2K-Wo and RL2K Fru2,6-Pase domain structures, with the exception of the role of
nine; H256A, a mutant form of RT2K-Wo with an additional histidine
256 to alanine mutation.
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His390, which is neither coupled to Glu325, nor in a position to
donate a proton to Fru-6-P. It is important to note, however,
that neither the RT2K-Wo nor the original RL2K Fru-2,6-Pase
domain structures contained bound ligands (Fru-6-P or Fru2,6-P2), which has hampered a thorough characterization of the
Fru-2,6-Pase mechanism. The report of a trapped RL2K phosphoenzyme intermediate (21) and the work presented here
combine to remedy this deficiency.
To facilitate our own crystallographic studies of the RT2K
kinase reaction, we generated a mutant protein, H256A, that
as reported for the RL2K H258A mutant (16), would be devoid
of phosphatase activity (and allow us to soak Fru-2,6-P2 into
crystals without consumption by the Fru-2,6-Pase reaction).
This enzyme unexpectedly retains 17% of the RT2K-Wo Fru2,6-Pase activity and led to a series of experiments to assess the
basis for this activity. The results of mutagenesis and kinetic
analyses on the Fru-2,6-Pase domain of the RT2K isozyme are
presented in a companion paper (1). We report here the crystallographic structure of the Fru-2,6-Pase domain of the RT2K
H256A mutant enzyme. This structure includes bound Fru-6-P
and PO4 ligands in the active site. Based on a comparison of the
RT2K-Wo, H256A mutant, and the RL2K phosphoenzyme
structures, we propose catalytic mechanisms that explain the
observed kinetic data for both mutant and wild type enzymes.

TABLE I
Structure determination statistics
Parameters

Values

Diffraction data
Resolution (Å)
No. of reflections (F $ 2s(F)
Completeness (%)
Multiplicity
I/s(I)
Rsym
Rwork
Rfree
Model composition
No. of amino acids
No. of protein atoms
No. of heteroatoms
No. of water molecules
No. of refinement parameters
Observations/parameter
Coordinate error (Å)
Luzzati
SIGMAA
Stereochemistry
Bond lengths (Å)
Bond angles (degrees)
Improper angles (degrees)
Thermal parameters
Mean B (main chain)
Mean B (side chain)
Mean B (protein/heteroatoms)
Mean B (solvent)
Root mean square deviation B bonded
Root mean square deviation B angles
Overall B (Wilson plot)

EXPERIMENTAL PROCEDURES

Protein Preparation and Crystallization—The preparation and purification of the Wo form of RT2K was described previously (22, 23). A
single point mutation of the Wo enzyme, converting His256 to Ala was
generated and purified by the same procedure (1). Crystallization was
performed by the hanging drop vapor diffusion method. The conditions
for crystallization were a modified version of those reported previously
(24). Briefly, 10 mg/ml of protein (in 50 mM TriszPO4, pH 7.5, 5%
glycerol, 40 mM EDTA, 40 mM EGTA, 800 mM dithiothreitol, 0.4%
PEG300, 1.7 mM Fru-6-P, 1.7 mM AMP-PNP, 1% b-octyl glucoside) was
mixed 1:1 with a well solution of 17% polyethylene glycol 4000, 60 –90
mM succinate, pH 6.0, 10% glycerol, and 10 mM MgCl2. Crystals were
grown and stored at 4 °C.
Data Collection and Processing—Crystals were serially transferred
into solutions of surrogate mother liquor (19% PEG 4000, 10 mM MgCl2,
90 mM succinate, pH 6.0, 50 mM TriszHCl, pH 7.5, 1% b-octyl glucoside,
10 mM Fru-6-P, and 1 mM AMP-PNP) with increasing concentrations of
glycerol (10 –20% in 5% steps). These cryoprotected crystals were flash
frozen in liquid propane and subsequently maintained at 120 K in a dry
nitrogen stream using an X-Stream crystal cooler (Molecular Structure
Corp). Data were collected on a DIP-2020 image plate detector (MacScience) mounted on a Rigaku rotating anode generator operated at 50
mA, 100 kV, with double mirror focusing (MacScience). Diffraction
intensities were integrated using the program Denzo (25). All data were
merged and scaled in Scalepack (25) and formatted for subsequent use
in XPLOR (26). Automatic indexing in Denzo indicated that the crystals
belong to space group P1, and postrefinement in Scalepack led to unit
cell dimensions a 5 61.74 Å, b 5 73.51 Å, c 5 76.70 Å; a 5 116.9°, b 5
99.31°, and g 5 105.2°. Assuming two molecules per asymmetric unit,
the calculated Matthews coefficient (27) is 2.54 Å3/Da.
Phasing by Molecular Replacement, Model Building, and Refinement—The rotation search and PC refinement were carried out in
XPLOR, using a polyalanine model derived from the RT2K-Wo crystal
structure (7). Because of the extensive interaction between monomers
in the original P3121 crystal form, we anticipated that the global dimer
structure would be unchanged in this new P1 crystal packing and thus
used the entire dimer as a search model, rather than separate searches
for the two monomers. The molecular replacement was unambiguous,
with a rotation function peak 7.4 s above the mean. Rigid body minimization of this rotation solution using data from 20- to 2.8-Å resolution
led to an Rfree of 0.51 for the polyalanine model and an Rfree of 0.42 with
all side chains included. To minimize model bias, initial electron density
maps were calculated with the polyalanine molecular replacement
phases and data from 30 to 2.4 Å, using SIGMAA (28) weighting as
implemented in XPLOR. Model rebuilding was accomplished using the
program O (version 6.1 (29)). The major changes in the structure are
related to changes in the ligand-binding state of both catalytic domains
and changes due to crystal packing. Refinement in XPLOR included the
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30–2.4
37,144
95.1 (93.1)
2.16 (2.14)
15.6 (4.75)
5.2
20.0
24.4
864a
7017
153
274
29,776
1.25
0.35
0.35
0.012
1.60
1.48
33.4
35.7
34.8
27.6
2.97
4.54
37.4

a
Each monomer is missing the first 36 amino acids. Thus, 864 5 2 3
(468 2 36).

use of noncrystallographic restraints. Four groups were defined (kinase-tight, kinase-loose, phosphatase-tight, and phosphatase-loose),
using a weight of 100 for the tighter and 50 for the looser restraints.
Rebuilding, positional, and B-factor refinement yielded the final model
reported here with indicators of model quality as reported in Table I.
Coordinates have been deposited with the Protein Data Bank (30), with
accession code 2bif.
RESULTS

Protein Crystallization and Structure Solution—Crystals of
the RT2K H256A mutant protein were grown by the hanging
drop vapor diffusion method as described under “Experimental
Procedures.” Crystals grew with a rod-shaped morphology and
were found to belong to space group P1. The unit cell dimensions are a 5 61.7 Å, b 5 73.5 Å, c 5 76.7 Å; a 5 116.9°, b 5
99.31°, and g 5 105.2°, and there are two monomers (the
functional dimer) in the asymmetric unit. These crystals diffract to 2.4 Å, and data were collected from specimens frozen at
cryogenic (120 K) temperatures. The structure was solved by
molecular replacement using the reported RT2K-Wo structure
as a search model. A summary of the overall data and model
qualities is presented in Table I. The overall structure of the
RT2K dimer is similar to that reported earlier (7), i.e. a close
interaction between kinase domains, with essentially independent phosphatase domains tethered to the kinase dimer.
Because there are two monomers in the asymmetric unit, we
have determined two independent structures of the monomer.
For the kinase domains, the two copies are different, with
subtle conformational changes, and different ligands bound.2
The two phosphatase domains are quite similar in conformation and bound ligands, although one copy has generally lower
B-factors (monomer A average B-factor 5 50.1; monomer B
average B-factor 5 32.3), due to closer crystal packing for the
phosphatase domain of monomer B. For this reason, subse2

M. H. Yuen and C. A. Hasemann, manuscript in preparation.

2178

Bisphosphatase Mechanism from Structure with Bound Fru-6-P

FIG. 1. Electron density of Fru-6-P bound in the Fru-2,6-Pase active site. A stereo view of the final molecular model of Fru-6-P bound in
the Fru-2,6-Pase active site is shown, with several neighboring amino acids labeled. The electron density mesh is drawn at the 4.5s contour of an
Fo 2 Fc difference map, calculated after Fru-6-P was omitted, and the model was subjected to 2,500 K simulated annealing in XPLOR (26). This
figure was generated using the program O (29).

quent results and discussion will generally be restricted to the
phosphatase domain of monomer B.
Fru-6-P Binding in the Active Site—In our previous structure
of RT2K-Wo, there was not a Fru-6-P molecule bound to the
Fru-2,6-Pase domain, despite its presence in the crystallization
mixture. Instead, there were phosphate ions bound in the presumed binding sites for the 2- and 6-phosphates of Fru-6-P. In
the structure of the RT2K H256A mutant reported here, there
is clear electron density for Fru-6-P in both monomers (Fig. 1).
The refined coordinates of the Fru-6-P molecule in the binding
site (Fig. 2) reveal that the Fru-6-P traverses a crevice composed of Ile267, Glu325, Tyr336, Arg350, Lys354, Tyr365, Gln391,
and Arg395. The polar residues form hydrogen bonds with the
Fru-6-P hydroxyls and 6-phosphate (Table II and Fig. 2), while
Ile267 forms a Van der Waals interaction by stacking with the
fructose ring (Fig. 3). Tyr336, Arg350, Lys354, and Tyr365 interact
with the 6-phosphate in exactly the same way that the free
phosphate was bound in the RT2K-Wo structure. Eight of the
nine oxygens of Fru-6-P are involved in direct hydrogen bonds
to the protein or to well ordered waters, which are in turn
bound by protein. Fru-6-P-O-1 interacts with two water molecules, which are in turn bound to main chain carbonyls and side
chains. Fru-6-P-O-2, which is of course the site of bond cleavage
from the 2-phosphate during the Fru-2,6-Pase reaction, forms a
hydrogen bond with Glu325, making Glu325 a prime candidate
for a catalytic residue, as will be discussed below. The main
chain nitrogen of Gly268 interacts with the Fru-6-P-O-3 hydroxyl, while the nitrogen of Gln391 forms two hydrogen bonds
to fructose oxygens (O-5 and O-6). Only Fru-6-P-O-4 is not
involved in a hydrogen bond interaction, and that is because
the stacking of Ile267 with the fructose ring includes an interaction with the C-4 –O-4 bond, preventing a close approach of
any other protein groups that might interact with Fru-6-P-O-4.
This mode of Fru-6-P binding (a combination of many hydrogen
bonds and hydrophobic stacking) is typical for carbohydrate
binding proteins that bind their substrate in an internal pocket
(type I proteins, as defined by Quiocho (31) and Vyas (32)) and
promotes both tight binding and substrate specificity.
Phosphate Binding at the 2-Phosphate Pocket—A phosphate
ion is bound in the 2-phosphate pocket of both monomers in the
crystal. The phosphate is in hydrogen bonding distance to the
side chains of Arg255, Glu325, Arg305, His390, Asn262, and the

main chain nitrogen of Gln391, as well as being in contact with
Fru-6-P-O-2. A superposition of the H256A and RT2K-Wo
structures shows that the phosphate occupies a different position in the two enzymes. In the H256A structure, the ion shifts
(by an average distance of 1.46 Å for the two monomers) to
occupy the space created by the loss of His256. While the phosphate still contacts the same set of protein atoms, most of the
hydrogen bonds are longer in the H256A mutant (Table III).
The phosphate in the H256A structure has, of course, lost its
interaction with His256 but has gained an interaction with
Fru-6-P.
Modeling Fru-2,6-P2 Binding in the Active Site—Superposition of the H256A crystal structure with the RT2K-Wo structure allows us to generate a model of Fru-2,6-P2 in the phosphatase active site. This is possible because the positions of the
6-phosphate and protein atoms in the active site have not
changed (root mean square coordinate change for 143 atoms 5
0.20 Å) beyond the intrinsic coordinate error of the H256A
model (0.35 Å). Thus, by combining the protein and 2-phosphate analogue from the RT2K-Wo structure with the Fru-6-P
from the H256A structure, we achieve an excellent approximation of the Fru-2,6-P2 complex (Fig. 3). The arrangement of
protein/Fru-6-P hydrogen bonds and Van der Waals interactions described above holds the Fru-2,6-P2 molecule in the ideal
orientation for an in-line associative transfer of the 2-phosphate to His256. Thus, the crystallographically determined location of Fru-6-P in the active site (and the model of Fru-2,6-P2)
allow us to re-evaluate the proposed catalytic mechanism in
more detail.
DISCUSSION

Fru-6-P and Fru-2,6-P2 Binding—The structure presented
here represents the first structure of a Fru-6-P-bound form of
an intact Fru-2,6-Pase domain in a dimeric Fru-6-P,2-kinase/
Fru-2,6-Pase. Fru-6-P is a potent inhibitor of Fru-2,6-Pase
activity at physiologic concentrations of Fru-6-P (Ki 5 51 nM,
hepatocyte concentration of 20 –50 mM). In the case of the RT2K
isozyme, this should result in an inhibited Fru-2,6-Pase activity and a net production of Fru-2,6-P2 and consequent driving
force for glycolysis in tissues that express this isozyme. Thus,
the elucidation of the mode of binding of this potent inhibitor is
itself significant. Recently, a structure of the truncated form of
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FIG. 2. Fru-6-P interactions in the Fru-2,6-Pase active site. A stereo view of the Fru-2,6-Pase active site is shown, with the protein bonds
colored tan, and the Fru-6-P and phosphate bonds magenta. The various interactions between protein and Fru-6-P that account for the affinity and
specificity of the active site are shown. The Fru-6-P 6-phosphate is shown at the top, bound by interactions with Arg350, Lys354, Tyr365, and Arg395.
The fructose portion of Fru-6-P is bound by both hydrogen bonds and a hydrophobic stacking interaction, where Ile267 can be seen to stack with
the fructose ring and Fru-6-P-O-2. The amide nitrogen of Gln391 has a bidentate interaction with the fructose at O-5 and O-6. The main chain
nitrogen of Ile267 is hydrogen-bonded to Fru-6-P-O-3. The two water molecules that form hydrogen bonds between Fru-6-P-O-1 and the protein are
shown as isolated red spheres. One of these waters interacts with Fru-6-P, Tyr336, and the main chain carbonyl of Thr443. The other water interacts
with Asn262 and the main chain carbonyl of position 266. The free phosphate (analogous to the 2-phosphate of Fru-2,6-P2) is shown at the bottom,
bound by Arg255, Asn262, Arg305, and His390. The identities of the side chains are indicated with the one-letter amino acid designation and position
in the RT2K protein sequence. The side chain of Thr443 has not been included so as not to obscure the view of F-6-P. Not labeled and at the back
of the image are Arg255, Glu325, and His390, interacting with the Fru-6-P molecule and/or the free phosphate. Hydrogen bonds between the Fru-6-P,
phosphate, and protein are drawn as black lines. This figure was produced using MOLSCRIPT (40) and rendered in Raster3D (41).
TABLE II
Fru-6-P interaction with the RT2K H256A mutant
Fru-6-P,2-kinase/Fru-2,6-Pase
Fru-6-P

Contact distance
Residue and atom
Monomer A

Monomer B
Å

O-2
O-3
O-5
O-6
O-61
O-62
O-63
C-3, C-4, O-4, C-5

Glu325 Oe2
Gly268 N
Gln391 Ne2
Gln391 Ne2
Tyr365 Oh
Arg350 Nh2
Arg395 Nh1
Lys354 Nz
Tyr336 Oh
Arg350 Nh1
Ile267 Ca, Cb, Cg2

2.83
3.03
2.62
3.19
2.78
2.65
2.76
2.86
2.75
3.17
3.8–4.1

2.60
2.86
2.73
3.06
2.70
2.69
2.92
2.59
2.78
3.36
3.6–4.2

an isolated RL2K Fru-2,6-Pase domain was determined with a
covalent phosphohistidine intermediate in the presence of Fru6-P (21). The position of the Fru-6-P molecule is notably different in the two structures. While it is impossible to say that one
conformation is correct and the other incorrect, there are several points that argue that the conformation of Fru-6-P reported here is more likely to be the native conformation. First,
the RL2K structures are of a truncated protein that is missing
30 C-terminal amino acids. The analogous stretch of polypeptide in our RT2K structure passes within 3.5 Å of the Fru-6-P
molecule, at Thr443. The carbonyl oxygen of Thr443 is in fact
hydrogen-bonded to a water, which in turn coordinates the
1-hydroxyl of Fru-6-P (see Fig. 2). In addition, the region of

RL2K structure that should have been occupied by the truncated protein is instead involved in a crystal contact, such that
amino acids from a neighboring molecule are within 5.8 Å of the
Fru-6-P. One of these amino acids (Gln342) actually interacts
with Gln393 (the analogue of Gln391 in RT2K). Remember that
Gln391 makes two hydrogen bonds with Fru-6-P that are important in maintaining its position in the active site (see Fig. 2).
Last, the Fru-6-P in the RL2K structure is in an unusual
conformation compared with two Fru-6-P and two Fru-1,6-P2
structures from the Cambridge small molecule data base. In
contrast, the Fru-6-P conformation reported here closely resembles the extended, low energy conformations determined by
small molecule crystallography. Finally, recall that Ile267 forms
a typical stacking interaction with the fructose ring in the
structure reported here. This stacking interaction is absent in
the RL2K structure.
The determination of a Fru-6-P-bound form of the RT2K
H256A Fru-2,6-Pase domain has allowed us to build a reliable
model of the Fru-2,6-P2-bound enzyme. As seen in Fig. 3, the
active site of the Fru-2,6-Pase domain is perfectly tailored to
accommodate Fru-2,6-P2. The active site serves as a molecular
ruler, measuring the length of the bound substrate along an
axis defined by the line between the Fru-6-P 2-hydroxyl and
His256 (5.5 Å in the RT2K-Wo structure; see Fig. 4). In this
space, there is room for one phosphate, one covalent bond to
phosphate (1.6 –1.8 Å), and one noncovalent interaction (;3.2
Å). Thus, Fru-2,6-P2 is accommodated, with a covalent Fru-6P-2-phosphate bond and the 2-phosphate in Van der Waals
contact with His256. After the catalytic transfer of the 2-phosphate to His256, the ruler is still satisfied, with a covalent
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FIG. 3. Model of Fru-2,6-P2 bound to the RT2K-Wo active site. We have constructed a model of Fru-2,6-P2 binding to the Fru-2,6-Pase active
site based on the coordinates of the RT2K-Wo structure (protein and 2-phosphate drawn with tan bonds) and the coordinates of Fru-6-P from the
H256A structure (Fru-6-P drawn with cyan bonds). We have not repositioned either the 2-phosphate or the Fru-6-P, so there is a small (0.9-Å) gap
between the Fru-6-P-O-2 and the phosphate oxygen. This gap would obviously not exist in Fru-2,6-P2, since these represent the same oxygen. The
catalytic His256 is positioned in-line with the O-2–P bond, while Asn262, His390, and Arg255 are arranged perpindicular to that line, in a position
to interact with the equatorial oxygens in the pentacoordinate transition state. Arg305 is not shown, to reduce the clutter in the figure but would
be positioned in the foreground, interacting with the phosphate oxygen that is shown interacting with His390. Glu325 is shown hydrogen-bonded
with Fru-6-P-O-2 and also interacting with the N terminus of helix a14 (labeled as 392 and 393). Ile267 is included to clearly demonstrate the
stacking interaction between this side chain and the Fru-6-P. The identity of the side chains are indicated with the one-letter amino acid
designation and position in the RT2K protein sequence. This figure was produced using MOLSCRIPT (40) and rendered in Raster3D (41).
TABLE III
Comparison of PO4 interaction in RT2K-Wo and RT2K-H256A
mutant (monomer B)
Distance
PO4

Residue and atom
RT2K-Wo

RT2K-H256A
Å

O-1

P
O-2
O-3
O-4

Arg255 Nh2
Arg255 Ne
Gln391 N
His256 Ne2
His256 Ne2
Glu325 Oe2
Fru-6-P O-2
Arg305 Nh2
Arg305 Ne
His390 Nd1
Asn262 Nd2

3.13
2.97
2.92
2.64
3.17
2.55
2.74
2.75
2.90
2.97

3.26
2.91
4.04
3.91
2.46
3.34
2.61
2.85
3.14

phosphohistidine and a noncovalent interaction between the
transferred 2-phosphate and Fru-6-P. However, there is not
enough room for either the combination of phosphohistidine,
hydrolytic water, and Fru-6-P or for a noncovalently bound
phosphate ion with a Fru-6-P molecule. In those cases, the
ruler would be measuring two noncovalent interactions, a distance that cannot be accommodated. The arrangement of molecules in the RL2K trapped phosphohistidine structure described above (E-PzH2OzFru-6-P) is an arrangement that
violates this molecular ruler concept. This violation is only
allowed because of the unnatural position of Fru-6-P in the
binding pocket, which is a consequence of the C-terminal truncation of the RL2K Fru-2,6-Pase domain.
Correlation of Structures with Kinetics—The molecular ruler
concept predicts an ordered reaction mechanism (Scheme I),
where Fru-6-P release must precede phosphohistidine hydrolysis. After Fru-6-P has dissociated, a water molecule would be
accommodated in the active site for hydrolysis of the E-P intermediate. This model is consistent with previous kinetic ex-

periments where it has been reported that the rate of phosphoenzyme formation is greater than the overall reaction rate
(33), that Fru-6-P inhibits the Fru-2,6-Pase reaction (34), that
Fru-6-P release is the rate-limiting step in the overall reaction
(35), and that Pi accelerates E-P hydrolysis by competing for
Fru-6-P binding (presumably at the 6-phosphate binding site)
(33). In our own studies, we showed that Fru-6-P release and
phosphohistidine breakdown occur in parallel in the wild type
enzyme (1). Together, the structural and kinetic data indicate
that E-P hydrolysis does not occur until after Fru-6-P has
dissociated from the enzyme, and that E-P hydrolysis is fast
(Scheme 1).
There have been several models of Fru-2,6-Pase catalysis
proposed, based first on mutagenesis directed by the homology
of the Fru-2,6-Pase domain to the phosphoglycerate mutase
family (16, 17) and later based on crystal structures (1, 7, 8, 21).
These studies have all concluded that all of the amino acids
that define the 2-phosphate binding pocket (His256, His390,
Arg255, Arg305, Asn262, and Glu325) are influential in catalysis.
Specifically, His256 has conclusively been demonstrated to act
as a nucleophile that attacks the 2-phosphate, resulting in a
His256 phosphohistidine intermediate (1, 13, 14, 21). His256 is
perfectly placed for an in-line attack that would break the
O-2–P-2 bond of Fru-2,6-P2 with an inversion of phosphate
geometry (Fig. 3). Our own data on the retention of significant
catalytic activity in the H256A mutant (1) are contradictory to
previous findings in the RL2K enzyme (16) and indicate that
this phosphoenzyme intermediate is not an obligatory intermediate for the enzyme. Arg255 and Arg305 have been proposed to
neutralize the charge of the 2-phosphate and/or to stabilize the
transition state (1, 18), consistent with their location as equatorial ligands to the 2-phosphate. Glu325 has been proposed to
act both to promote the protonation of His390 and to polarize a
water molecule as a nucleophile for attack on the phosphohistidine intermediate (8, 17, 21). The capacity of Glu325 to alter
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FIG. 4. The “molecular ruler” of the
Fru-2,6-Pase active site. Based on the
position of Fru-6-P in the Fru-2,6-Pase
active site, there is a 5.5-Å distance between the reactive nitrogen of the catalytic histidine and the 2-OH of Fru-6-P
(shown as the dark bar at the top). This
distance can accommodate either an
EzFru-2,6-P2 or E-PzFru-6-P complex but
would preclude either an E-PzH2OzFru6-P or EzPzFru-6-P complex. The dark
bars below each complex represent ideal
bond lengths or approximate Van der
Waals contact distances.

the pKa of His390 is doubtful, since the ionizable groups of these
amino acids are not near each other (see Figs. 2 and 3). The role
for Glu325 as a catalytic base in phosphohistidine hydrolysis is
consistent with both its location in the structure and the available kinetic data on Glu325 mutants (1, 17). Finally, His390 has
been proposed to act as a catalytic acid, donating a proton to
the leaving group O-2 of Fru-6-P (8, 16). This, however, is
inconsistent with the structure, since His390 is not in the vicinity of the leaving group (Fig. 3), nor does it exist in an environment that would promote its protonation. Our kinetic data
from the H390A mutant protein are also inconsistent with its
role as a proton donor to the leaving group, in that this mutant
protein demonstrates a lag in phosphate release after Fru-6-P
release (1), indicating that His390 is involved in phosphohistidine hydrolysis. Thus, the role of H390, the mechanism of
catalysis in the H256A mutant, and the identity of the proton
donor for the leaving group O-2 of Fru-6-P remain unresolved
from previous findings. We believe that the Fru-2,6-Pase ki-

netic data (as cited above) and the structural findings reported
here lead to a complete catalytic mechanism for the wild type
enzyme and a distinct mechanism for the H256A mutant
enzyme.
Wild Type Mechanism—Fig. 5 shows a Fru-2,6-Pase catalytic
cycle where Glu325 is the sole amino acid involved in proton
exchanges. At the beginning of the cycle (EzFru-2,6-P2 from
Scheme I), His256 attacks the phosphate, leading to a pentacoordinate transition state, with the excess negative charge of the
transition state being stabilized by Arg255, Asn262, Arg305, and
His390. A protonated Glu325 then donates a proton to the leaving Fru-6-P. As discussed above, Fru-6-P dissociation must
precede the next step, where the ionized Glu325 polarizes a
water molecule for attack on the phosphohistidine intermediate, regenerating the ground state of the enzyme. The attractive features of this model are its simplicity and its consistency
with both the kinetic and structural data. The proximity of
Glu325 to the 2-oxygen of Fru-6-P and/or the model of Fru-
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FIG. 5. Fru-2,6-Pase catalytic cycle. The proposed mechanism begins with formation of the EzFru-2,6-P2 complex shown in the upper left panel.
His256 attacks the 2-phosphate, resulting in a tetrahedral intermediate that is stabilized by its interactions with Arg305, Arg255, His390, and Asn262
as shown in the upper right panel. A proton derived from Glu325 then joins the leaving group Fru-6-P as the O-2–P bond is broken. The resulting
E-PzFru-6-P complex is stable, and Fru-6-P release from the active site is rate-limiting. After Fru-6-P diffuses out of the active site, a water
molecule will diffuse in. Glu325 then activates the water as a nucleophile to attack the E-P intermediate as shown in the lower right panel. The E-P
hydrolysis requires the formation of another tetrahedral intermediate, again stabilized by Arg305, Arg255, His390, and Asn262 (not shown). Finally,
the free phosphate remains bound in the 2-phosphate binding site (lower left panel) until it is displaced by another molecule of Fru-2,6-P2,
restarting the cycle.

2,6-P2 and the kinetic data from Glu325 mutants that show a
drastic loss of Fru-2,6-Pase activity (1, 17) make Glu325 a prime
candidate for a major role in catalysis. Glu325 is well positioned
for proton transfer to the 2-oxygen of Fru-6-P (Fig. 3, and Table
II) and is well positioned to polarize water for attack on the
phosphohistidine intermediate (21). The role of the amino acids

that are equatorial ligands in transition state stabilization is
consistent with the decreases in kcat/Km that are observed when
they are mutated to amino acids that cannot fill this role.
Where it has been studied, mutation of these equatorial ligands
clearly affects both transition states (i.e. phosphohistidine formation and phosphohistidine hydrolysis). Note that His390,
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which had previously been designated as a proton donor, is now
simply another equatorial ligand. This is consistent with the
kinetic data, where His390 mutations have effects similar to the
mutation of other equatorial ligands. Most important though,
is the observation that the H390A mutation causes a significant lag in Pi release after Fru-6-P release (1). This lag in Pi
release is consistent with the role of His390 in transition state
stabilization but not consistent with His390 as a proton donor to
Fru-6-P.
There is one significant problem with this mechanism. The
crystal structure clearly shows that Glu325 is capping the N
terminus of an a-helix (a14, amino acids 391– 400, Fig. 3). Such
a protein environment would shift the pKa of Glu325 such that
the existence of a protonated Glu325 is unlikely, making it a
poor choice for the proton donor in Fru-6-P release. On the
other hand, this is in fact an enzyme with a low turnover (i.e.
the wild type RT2K Fru-2,6-Pase reaction has a kcat of 0.032
s21). Because the biological role of the enzyme is regulatory and
is not a step in a biosynthetic pathway, it makes some teleological sense that the enzyme would be slow. As such, a rare
protonation of Glu325 and subsequent proton donation to Fru6-P could be tolerated. This idea of a slow Glu325 protonation is
not in agreement with the kinetic evidence, however, since
phosphohistidine formation has been reported to be 2 orders of
magnitude faster than the overall rate of catalysis, with the
Fru-6-P release rate-limiting (34, 35). It is possible that Fru2,6-P2 binding to the active site shifts the Glu325 pKa via the
interaction of the 2-phosphate with the N terminus of helix a14
(Fig. 3).
One approach to address this apparent Glu325 paradox would
be pH titration kinetics of phosphohistidine formation in the
wild-type and active site mutant enzymes to determine the pKa
values for Glu325 and other active site residues. Pilkis and
co-workers reported the pH titration of kcat/Km for wild type,
H392A, and E327Q mutant forms of the RL2K enzyme (36).
Their results with the wild type eznyme indicated two ionizable
groups with pKa values of 6.1 and 8.4, which we would interpret as the pKa of a Fru-2,6-P2 phosphate and an unidentified
residue of the protein, respectively. The titration profiles of the
H392A and E327Q mutants clearly showed a partial change in
the low end pKa with an increase in the pKa. The curves were
complex however, suggesting the possibility of compensating
charge interactions. It is evident that further experiments in
this area will be necessary to clarify the role of ionizable groups
in the Fru-2,6-P2ase active site.
H256A Catalysis: Hydrolysis Versus Phosphohistidine 390 —
The discovery that the H256A mutant of RT2K has 17% of the
wild type bisphosphatase activity has led to two alternative
explanations of the mechanism (1). Either the enzyme is able to
utilize His390 as an alternate to His256 as a nucleophile to form
a phosphohistidine 390 intermediate, or another as yet undetermined mechanism exists for the H256A mutant. Examination of the active site structure (Fig. 3) leads to the conclusion
that the transfer of a phosphate to His390 is quite unlikely. As
noted above, His256 is ideally positioned for the in-line transfer
of phosphate from Fru-2,6-P2. His390, on the other hand, is
nearly 90° off this transfer axis, ideal positioning for an equatorial ligand to the transition state intermediate, but horribly
suited for an in-line phosphotransfer. In order to accomplish a
phosphotransfer to His390, either by direct in-line attack or by
an attack from the side followed by pseudorotation (37, 38), the
substrate and/or His390 would have to be repositioned in the
active site. The position of His390 is of course constrained by the
fold of the protein and thus could not move from its equatorial
location to an axial position. Manual remodeling of Fru-6-P in
the active site to a position that would lead to an axial His390
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led only to steric clashes of Fru-6-P with protein. From this
evidence, combined with the inability to detect a phosphohistidine intermediate in the H256A mutant by several methods
(1), we conclude that a phosphohistidine 390 intermediate
pathway is not at all likely.
An alternative hypothesis is that the H256A mechanism
involves the direct hydrolysis of Fru-2,6-P2 by water. Due to the
deletion of His256, there is a hole in the enzyme where the
imidazole ring used to be. In the crystal structure, this hole is
occupied by a free phosphate as described above (Fig. 2 and
Table III). When we model Fru-2,6-P2 bound to the enzyme by
superimposing the H256A and RT2K-Wo structures, this hole
would be empty in the H256A substrate complex. Since vacuums do not exist in proteins, this space will be filled, and most
likely by a water molecule. Like the imidazole of His256, this
water molecule would be in the perfect position for an in-line
transfer of the phosphate. The equatorial ligands to the phosphate remain in the same position in both the RT2K-Wo and
H256A structures, so they would be competent to stabilize this
hydrolytic transition state in the mutant enzyme. The best
experiment to verify this hypothesis would be to utilize a synthetic Fru-2,6-P2 that has been triply labeled at the 2-phosphate with 16O, 17O, and 18O, generating a chiral phosphate. In
the event of a direct hydrolysis, there will be an inversion of the
phosphate stereochemistry, while for a two-step process involving a phosphohistidine intermediate, there will be retention of
stereochemistry. Such an experiment was used to verify the
phosphohistidine intermediate in phosphoglycerate mutase
(39).
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